The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday. Shares ...

The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday. Shares of the Cleveland-based drugmaker rose 13% in premarket trading. The gene ...

Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis ...

Krystal Biotech ( NASDAQ: KRYS) said that the European Commission granted marketing authorization to Vyjuvek for the treatment of wounds in certain patients with dystrophic epidermolysis bullosa, or ...

VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a ...

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

Vedder's work leveraging the fame and draw of his band's shows for curing epidermolysis bullosa (EB) has been turned into a ...

Abeona Therapeutics' pz-cel gene therapy shows the most durable wound healing in RDEB patients. See why I rate ABEO stock a ...

Hannah Campbell announced the tragic news of her infant's death on April 8 with a TikTok post shared to over 769,000 ...

INmune Bio Inc. (NASDAQ: INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the ...

You have a few choices to help the problem. If you only have a mild curve and your sex life and erections are good, you probably don't need treatment. If sex is hard or impossible, medicines ...